Mbabazi Phoebe, Chen Geoffrey, Ritchie Christine S, Tsai Alexander C, Reynolds Zahra, Paul Robert, Seeley Janet, Tong Yao, Hoeppner Susanne, Okello Samson, Nakasujja Noeline, Olivieri-Mui Brianne, Tanner Jeremy A, Saylor Deanna, Asiimwe Stephen, Siedner Mark J, Greene Meredith
Research Department, Infectious Disease Institute, Makerere University, Kampala, Uganda.
Department of Medicine, Medical Practice Evaluation Center, Mongan Institute, Massachusetts General Hospital, Boston, MA.
J Acquir Immune Defic Syndr. 2024 Dec 1;97(4):402-408. doi: 10.1097/QAI.0000000000003513.
The relationship between HIV and frailty, a predictor of poor outcomes in the face of stressors, remains unknown in older people in sub-Saharan Africa.
We analyzed data from the Quality of Life and Ageing with HIV in Rural Uganda cohort study to estimate the prevalence and correlates of frailty among older people with HIV (PWH) on long-term antiretroviral therapy and among age- and sex-matched HIV-uninfected comparators. Frailty was defined as a self-report of 3 or 4 (and pre-frailty as 1 or 2) of the following phenotypic variables: weight loss, exhaustion, low activity, and slowness. We estimated the prevalence of frailty and prefrailty and fitted logistic regression models to estimate the association between HIV and frailty, adjusting for sociodemographic factors, depression, and other comorbidities.
We enrolled 599 participants (49% women) with a mean age of 58 years. PWH had a similar prevalence of frailty (8.1% vs. 10.9%, P = 0.24) but a lower prevalence of prefrailty (54.2% vs. 63.2%, P = 0.03) compared with their HIV-uninfected comparators. In multivariable regression models, people with depression [adjusted odds ratio (AOR) 7.52 (95% CI: 3.67 to 15.40), P < 0.001] and those with ≥1 comorbidities [AOR 3.15 (95% CI: 1.71 to 3.82), P < 0.001] were more likely to be frail. HIV serostatus was not significantly associated with frailty [AOR 0.71 (95% CI: 0.37 to 1.34), P = 0.29].
Older PWH had a similar prevalence of frailty as those without HIV. These findings call for additional study of the factors that contribute to the robustness of older PWH in sub-Saharan Africa.
在撒哈拉以南非洲的老年人中,面对压力源时,作为不良结局预测指标的HIV与虚弱之间的关系尚不清楚。
我们分析了乌干达农村地区HIV感染者生活质量与老龄化队列研究的数据,以估计长期接受抗逆转录病毒治疗的HIV感染老年人(PWH)以及年龄和性别匹配的未感染HIV对照者中虚弱的患病率及其相关因素。虚弱定义为以下表型变量中自我报告有3项或4项(虚弱前期为1项或2项):体重减轻、疲惫、活动量低和行动迟缓。我们估计了虚弱和虚弱前期的患病率,并拟合逻辑回归模型以估计HIV与虚弱之间的关联,同时对社会人口学因素、抑郁和其他合并症进行了校正。
我们纳入了599名参与者(49%为女性),平均年龄为58岁。与未感染HIV的对照者相比,PWH的虚弱患病率相似(8.1%对10.9%,P = 0.24),但虚弱前期患病率较低(54.2%对63.2%,P = 0.03)。在多变量回归模型中,抑郁患者[调整优势比(AOR)7.52(95%CI:3.67至15.40),P < 0.001]和有≥1种合并症的患者[AOR 3.15(95%CI:1.71至3.82),P < 0.001]更有可能虚弱。HIV血清学状态与虚弱无显著关联[AOR 0.71(95%CI:0.37至1.34),P = 0.29]。
老年PWH的虚弱患病率与未感染HIV者相似。这些发现呼吁对撒哈拉以南非洲老年PWH保持强健的因素进行更多研究。